About four months after beginning its hunt for a new CEO to replace Don Casey—and amid an ongoing investigation into past financial practices—Dentsply Sirona’s search is complete. Taking over Casey’s ...

Management reaffirmed the full-year 2025 guidance for organic sales to decline by 2%-4% and adjusted EPS to remain in the range of $1.80 to $2. Reported sales guidance was revised upward to $3.6 ...

Cheree Johnson, who joined the company in March 2022, stepped down from the role last month. She became special advisor to the CEO, while medical industry in-house counsel veteran Richard Rosenzweig ...

In what's being billed as a merger of equals, dental device bigwigs Dentsply International ($XRAY) and Sirona Dental Systems ($SIRO) are joining forces in an all ...

Throughout the last three months, 5 analysts have evaluated Dentsply Sirona (NASDAQ:XRAY), offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ...

DENTSPLY SIRONA Inc. has appointed Daniel Scavilla as President and Chief Executive Officer, effective August 1, 2025, succeeding Simon Campion, who will depart the company on July 31, 2025. Scavilla ...

Dental products company Dentsply Sirona (NASDAQ:XRAY) met Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 4.9% year on year to $936 million. The company’s outlook for the full year ...

Dentsply Sirona, Inc. XRAY has voluntarily suspended sales and marketing of its Byte Aligners and Impression Kits as part of a regulatory review with the FDA. During this suspension, shipments and new ...

Dentsply Sirona (NASDAQ:XRAY) and ZimVie Inc. (NASDAQ:ZIMV) show below-market growth and have no meaningful upside, according Needham analysts. What Happened: Needham downgraded the two dental ...